Other Barks & Bites for Friday, September 12: Novartis Loses Challenge to IRA Drug Price Negotiation Program; Lutnick Wants a Share of University IP Licensing; and EUIPO Announces First Copyright Conference
Latest Director Discretionary Denial Decisions Mostly Deny Institution, But Two Cases Defy ‘Settled Expectations’ Trend